Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Form 4 filing overview
On 07/11/2025, Aehr Test Systems (AEHR) Chief Technology Officer Donald P. Richmond II reported a tax-related share withholding. The company retained 225 shares of common stock at $14.11 each to satisfy withholding obligations triggered by the vesting of restricted stock units. This administrative entry is coded “F,” indicating no open-market sale or purchase. After the transaction, Richmond’s direct ownership totals 215,505 shares, a figure that still includes unvested RSUs. No derivative security movements were disclosed.
The 225-share amount represents far less than 1 % of the insider’s holdings and does not alter the company’s share count or insider ownership structure in any material way, suggesting a neutral impact for investors.
Aehr Test Systems (AEHR) – Form 4 insider filing
On 07/11/2025, President & CEO Gayn Erickson reported an automatic share withholding related to the vesting of restricted stock units (Transaction Code F). A total of 1,052 common shares were surrendered at $14.11 solely to cover tax-withholding obligations; no open-market sale occurred.
Following the transaction, Erickson’s ownership stands at 277,029 shares held directly and 291,088 shares held indirectly through a trust. The filing reiterates that the reported figure includes unvested RSUs and restricted shares.
Because the event is tax-related and involves a small fraction of the executive’s total holdings, it is viewed as neutral from a market-impact perspective.
On 07/11/2025, Aehr Test Systems (AEHR) filed a Form 4 detailing a routine Code F transaction by Vice President Alistair N. Sporck. The company withheld 312 common shares at an implied price of $14.11 to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs); no open-market sale occurred. After the withholding, Sporck’s direct ownership totals 33,808 shares, with an additional 3,993 shares held indirectly through a trust. The total includes unvested RSUs, and no derivative securities were involved. Because the activity is purely administrative and does not alter the insider’s investment exposure, the filing is viewed as neutral for investors.
Aehr Test Systems (AEHR) filed a Form 4 disclosing that President & CEO Gayn Erickson had 2,489 common shares withheld on 07/11/2025 (transaction code F) at a price of $14.11 per share. The shares were automatically withheld by the issuer to cover statutory tax obligations triggered by the vesting of previously granted equity awards; no open-market sale occurred. After the withholding, Erickson retains 278,081 shares held directly and 291,088 shares held indirectly through a trust. The reported withholding represents less than 1 % of the executive’s aggregate beneficial ownership and does not signal a discretionary reduction in exposure to AEHR stock.
On July 11, 2025, Aehr Test Systems (ticker AEHR) Chief Operating Officer Adil Engineer filed a Form 4 reporting an administrative share disposition. The filing shows a Transaction Code "F," signifying that 580 common shares were automatically withheld at $14.11 each to cover tax obligations arising from the vesting of restricted stock units (RSUs). The aggregate value is roughly $8.2 thousand.
After the withholding, the executive continues to directly own 47,167 common shares, which includes unvested RSUs (as noted in footnote 2). No derivative securities were acquired or disposed of, and there were no open-market sales. Because the transaction is non-discretionary and involves a small share count relative to the officer’s total holdings, it is viewed as neutral in terms of market impact.
Aehr Test Systems (AEHR) Form 4 Filing Overview
Director Fariba Danesh reported the receipt of 9,253 shares of AEHR common stock on July 2, 2025 under a restricted stock unit (RSU) award, coded “A” for acquisition at a price of $0. After the grant, Danesh directly owns 25,643 shares, a total that includes unvested RSUs. The award vests in equal one-eighth installments every three months, contingent upon continued service on the board. No derivative securities were exercised or disposed of, and no open-market transactions occurred.
The filing appears to be part of routine director compensation rather than a discretionary purchase or sale. As such, it does not signal a material shift in ownership structure or insider sentiment, but it does modestly increase the director’s equity alignment with shareholders.